Empress Therapeutics emerges with $50m to fund small molecule development
Pharmaceutical Technology
JUNE 21, 2023
Life sciences venture capital firm Flagship Pioneering has unveiled Empress Therapeutics, a small molecule drug development startup. This will support development of its proprietary Chemilogics platform and drug discovery pipeline. So far, Empress claims to have generated 15 drug leads across multiple indications.
Let's personalize your content